These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Low μ-Opioid Receptor Status in Alcohol Dependence Identified by Combined Positron Emission Tomography and Post-Mortem Brain Analysis. Hermann D; Hirth N; Reimold M; Batra A; Smolka MN; Hoffmann S; Kiefer F; Noori HR; Sommer WH; Reischl G; la Fougère C; Mann K; Spanagel R; Hansson AC Neuropsychopharmacology; 2017 Feb; 42(3):606-614. PubMed ID: 27510425 [TBL] [Abstract][Full Text] [Related]
12. [11C]Carfentanil Binds Preferentially to μ-Opioid Receptor Subtype 1 Compared to Subtype 2. Eriksson O; Antoni G Mol Imaging; 2015; 14():476-83. PubMed ID: 26461068 [TBL] [Abstract][Full Text] [Related]
13. Interindividual variability and lateralization of μ-opioid receptors in the human brain. Kantonen T; Karjalainen T; Isojärvi J; Nuutila P; Tuisku J; Rinne J; Hietala J; Kaasinen V; Kalliokoski K; Scheinin H; Hirvonen J; Vehtari A; Nummenmaa L Neuroimage; 2020 Aug; 217():116922. PubMed ID: 32407992 [TBL] [Abstract][Full Text] [Related]
14. Building up analgesia in humans via the endogenous μ-opioid system by combining placebo and active tDCS: a preliminary report. DosSantos MF; Martikainen IK; Nascimento TD; Love TM; DeBoer MD; Schambra HM; Bikson M; Zubieta JK; DaSilva AF PLoS One; 2014; 9(7):e102350. PubMed ID: 25029273 [TBL] [Abstract][Full Text] [Related]
15. Reduced mu opioid receptor availability in schizophrenia revealed with [ Ashok AH; Myers J; Reis Marques T; Rabiner EA; Howes OD Nat Commun; 2019 Oct; 10(1):4493. PubMed ID: 31582737 [TBL] [Abstract][Full Text] [Related]
16. Mu Opioid Receptor Binding Correlates with Nicotine Dependence and Reward in Smokers. Kuwabara H; Heishman SJ; Brasic JR; Contoreggi C; Cascella N; Mackowick KM; Taylor R; Rousset O; Willis W; Huestis MA; Concheiro M; Wand G; Wong DF; Volkow ND PLoS One; 2014; 9(12):e113694. PubMed ID: 25493427 [TBL] [Abstract][Full Text] [Related]
17. Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects. Johansson J; Hirvonen J; Lovró Z; Ekblad L; Kaasinen V; Rajasilta O; Helin S; Tuisku J; Sirén S; Pennanen M; Agrawal A; Crystal R; Vainio PJ; Alho H; Scheinin M Neuropsychopharmacology; 2019 Aug; 44(9):1667-1673. PubMed ID: 30867551 [TBL] [Abstract][Full Text] [Related]
18. Determination of the in vivo selectivity of a new κ-opioid receptor antagonist PET tracer 11C-LY2795050 in the rhesus monkey. Kim SJ; Zheng MQ; Nabulsi N; Labaree D; Ropchan J; Najafzadeh S; Carson RE; Huang Y; Morris ED J Nucl Med; 2013 Sep; 54(9):1668-74. PubMed ID: 23918735 [TBL] [Abstract][Full Text] [Related]
19. Acute acetate administration increases endogenous opioid levels in the human brain: A [ Ashok AH; Myers J; Frost G; Turton S; Gunn RN; Passchier J; Colasanti A; Marques TR; Nutt D; Lingford-Hughes A; Howes OD; Rabiner EA J Psychopharmacol; 2021 May; 35(5):606-610. PubMed ID: 33406950 [TBL] [Abstract][Full Text] [Related]
20. Endogenous Opioid Mechanisms Are Implicated in Obesity and Weight Loss in Humans. Burghardt PR; Rothberg AE; Dykhuis KE; Burant CF; Zubieta JK J Clin Endocrinol Metab; 2015 Aug; 100(8):3193-201. PubMed ID: 26108093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]